ICON Launches New ICON Signature Series to Share Expertise and Insight into Clinical Development

[at noodls] – Dublin, Ireland, 21 March 2013 – ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it … more

View todays social media effects on ICLR

View the latest stocks trending across Twitter. Click to view dashboard

See who ICON is hiring next, click here to view